Training to improve metacognitive skills in patients with psychotic disorders
Does Group-Based Metacognitive Skills Training Reduce Jumping to Conclusions Bias of Patients With Psychotic Disorders in the Context of Forensic Psychiatric Care
This study is testing whether a group program that teaches metacognitive skills can help people with psychotic disorders improve their thinking and social skills.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 85 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | University of Jyvaskyla Academic / other |
| Locations | 1 site (Vaasa) |
| Trial ID | NCT06005766 on ClinicalTrials.gov |
What this trial studies
This study investigates the efficacy of group-based Metacognitive Skills Training (MCT) for patients diagnosed with psychotic disorders, such as schizophrenia and schizoaffective disorder. The intervention aims to enhance social cognition and metacognitive abilities, which are often deficient in these patients and linked to violent behavior. Participants will be compared to control groups using a psychological test battery to assess changes in cognitive and psychiatric symptoms over time. The study is conducted at Vanha Vaasa Hospital, where participation in MCT is integrated into standard care.
Who should consider this trial
Good fit: Ideal candidates include individuals diagnosed with a psychosis spectrum disorder who are willing to participate and have sufficient Finnish language skills.
Not a fit: Patients with severe cognitive problems or those under guardianship for personal matters may not benefit from this study.
Why it matters
Potential benefit: If successful, this training could significantly reduce violent behavior and improve social functioning in patients with psychotic disorders.
How similar studies have performed: Previous studies have shown that similar interventions, like Social Cognition Interaction Training, have successfully reduced violent behavior in psychotic patients.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria (patients): * Willingness to participate in a scientific study * Diagnosis of a psychosis spectrum disorder * Finnish language skills due to questionnaires and psychological tests being in Finnish Exclusion Criteria (patients): * Psychosis that severely deteriorates the ability to function * Cognitive problems that severely deteriorate the ability to function * Guardianship established for personal matters Inclusion Criteria (non-patient controls): * Willingness to participate in a scientific study * Self-assessed sufficient Finnish language skills due to questionnaires and psychological tests being in Finnish Exclusion Criteria (non-patient controls): * Diagnosis of a psychosis spectrum disorder * Cognitive problems that severely interferes with functioning
Where this trial is running
Vaasa
- Vanha Vaasa Hospital — Vaasa, Finland (Recruiting)
Study contacts
- Principal investigator: Raimo Lappalainen, PhD — University of Jyvaskyla
- Study coordinator: Leo Kuutti, MA
- Email: leo.kuutti@vvs.fi
- Phone: 029 524 3058
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.